Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real worldPei Zhang, Fang Liu, Xiaobin Hou et al.|Annals of Translational Medicine|2022Cited by 8
Long-term efficacy and predictors of pembrolizumab-based regimens in patients with advanced esophageal cancer in the real worldHong-Chi Wang, Fang Liu, Baolin Qu et al.|World Journal of Gastroenterology|2023Cited by 8